Question 1

How do I set a price alert for AQST?

Accepted Answer

To set a AQST price alert on Stock Alarm Pro, navigate to the AQST quote page, select "Set Alert," choose your trigger type (price target, % move, RSI level, MACD, or volume breakout), and set your delivery channel. Stock Alarm Pro supports instant push notifications, SMS, and automated phone call alerts.

Question 2

Can I get phone call alerts for AQST?

Accepted Answer

Yes. Stock Alarm Pro provides real-time automated phone call alerts for AQST. Phone call alerts ensure you are immediately awakened or interrupted during critical volatility events, overnight earnings moves, or strict stop-loss levels when silent push notifications might be overlooked.

Question 3

What types of alerts can I set for Aquestive Therapeutics Inc?

Accepted Answer

Stock Alarm Pro supports over 125 trigger types for AQST: price target alerts (above/below target), intraday percentage moves, RSI overbought/oversold levels, 50-day and 200-day moving average crossovers (golden cross / death cross), relative volume (RVOL) spikes, confirmed earnings date releases, and SEC Form-4 insider transaction filings.

Question 4

How quickly will I be notified about AQST price changes?

Accepted Answer

AQST alerts are evaluated continuously in real-time against live market telemetry. Notifications are dispatched within sub-second latency via push notifications, SMS, or phone calls as soon as your trigger condition is met across regular, pre-market, and after-hours trading sessions.

Question 5

Is Stock Alarm Pro free to use for AQST alerts?

Accepted Answer

Yes, Stock Alarm Pro offers a free tier that includes 3 active price alerts for AQST and other stocks. Full Pro membership is $20/month or $168/year with a 7-day free trial, unlocking unlimited alerts, phone call delivery, SMS, all 125+ technical indicators, institutional screeners, and real-time market telemetry across web, iOS, and Android.

	Reported			Consensus estimates
Fiscal period	FY2023Dec '23	FY2024Dec '24	FY2025Dec '25	FY2026Dec '26	FY2027Dec '27	FY2028Dec '28	FY2029Dec '29	FY2030Dec '30
Revenue (M)	50.6	57.6	44.5	49.5	67.9	102.1	179.2	298.2
Growth YoY	+6.1%	+13.8%	−22.6%	+11.1%	+37.2%	+50.4%	+75.4%	+66.4%
High estimate	–	–	–	50.3	72.8	123.8	221.9	369.4
Low estimate	–	–	–	48.7	64.5	75.4	152.5	253.9
Analysts	–	–	–	6	7	5	2	2
EPS, adjusted	−0.14	−0.52	−0.78	−0.47	−0.49	−0.36	−0.03	0.38
Growth YoY	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m
High estimate	–	–	–	−0.44	−0.40	−0.15	−0.03	0.49
Low estimate	–	–	–	−0.52	−0.62	−0.65	−0.04	0.30
Analysts	–	–	–	4	4	4	1	1

Firm	Analyst	Rating	Prev rating	Target	Prev target	Chg	Upside	Date
H.C. Wainwright	Raghuram Selvaraju	Buy · Aug 2026	Buy	$10.00	$9.00	+11%	+156%	Oct 16
Cantor Fitzgerald	Kristen Kluska	–	–	$11.00	–	–	+181%	Sep 10
Lake Street	–	Buy · Mar 2025	Buy	$6.00	–	–	+53%	Feb 3
New Street	–	–	–	$12.00	–	–	+207%	Feb 2

Explore More

S&P 500 Sector Leaderboards

Fundamental Metric Rankings

Consensus

Price vs analyst targets

Revenue and EPS estimates

Brokers